Drugs / Ketorolac-Phenylephrine Ophthalmic 0.3%-1% Intraocular Solution
last change Aug 2024 re-read 2 minutes ago

Ketorolac-Phenylephrine Ophthalmic 0.3%-1% Intraocular Solution

Developed for
cystoid macular edema

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05158699 Comparator Oct 2021 → Aug 2024 cataract, cystoid macular edema Luigi Rondas Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ketorolac-Phenylephrine Ophthalmic 0.3%-1% Intraocular Solution ClinicalTrials.gov intervention name — accepted as the source's own label NCT05158699
Route Other “intracameral injection of ketorolac tromethamine solution during cataract surgery (Omidria)” NCT05158699